Tech Company Financing Transactions
Pheast Therapeutics Funding Round
On 4/26/2022, Pheast Therapeutics raised $76 million in Series A funding from Arch Venture Partners, Catalio Capital Management and Alexandria Venture Investments.
Transaction Overview
Arch Venture Partners (Lead Investor)
Catalio Capital Management (Lead Investor)
Company Information
Palo Alto, CA Undisclosed
United States
Management Team
Browse more venture capital transactions:
Prev: 4/26/2022: Qualified.com venture capital transaction
Next: 4/26/2022: Adept AI Labs venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs